Kyverna Therapeutics, Inc.
(NASDAQ: KYTX)
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
7.961
+0.121
(+1.54%)
Range
7.800 - 7.993
(2.47%)
Open
7.920
Previous Close
7.840
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
34,762
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
